CN
213-193-3
应用筛选条件
关键词:'213-193-3'
显示 1-30 共 80 条结果 关于 "213-193-3" 范围 技术文档
Product Information Sheet - C0138
cis in the presence of light.
References
1. Carter, S.B., Nature, 213, 261 (1967).
2. Krishan, A. J., Cell Biol., 54, 657 (1972).
3. Prescott, D.M. et al., J. Exp. Cell Res., 71, 480
(1972).
4. Carter
Product Information Sheet - C1139
cis in the presence of light.
References
1. Carter, S.B., Nature, 213, 261 (1967).
2. Krishan, A. J., Cell Biol., 54, 657 (1972).
3. Prescott, D.M. et al., J. Exp. Cell Res., 71, 480
(1972).
4. Carter
Product Information Sheet - B3279
micro-
environment. Biochem. J., 247(1), 181-193 (1987).
4. Singh, R. et al., An amplified assay for thiols based
on reactivation of papain. Anal Biochem., 213(1),
49-56 (1993).
5. Dallas Johnson
Data Sheet - I7139
References
1. Smith, K., Science, 240, 1169 (1988).
2. Morgan, D., et al., Science, 193, 1007 (1976).
3. Ortaldo, J., et al., J. Immunol., 133, 779 (1984).
4. Farrar, J., et al., Immunol. Rev
Data Sheet - I6013
mycoplasm.
References
1. Smith, K., Science, 240, 1169 (1988).
2. Morgan, D., et al., Science, 193, 1007 (1976).
3. Ortaldo, J., et al., J. Immunol., 133, 779 (1984).
4. Farrar, J., et al., Immunol. Rev, 63
Data Sheet - PPC1010
et al., Effect of
bromotetramisole on renal phosphate excretion.
Proc. Soc. Exp. Biol. Med., 213, 193-195 (1996).
7. Runnegar, M.T. et al., Differential toxicity of the
protein phosphatase inhibitors
Product Information - P0001
Effect of
bromotetramisole on renal phosphate
excretion. Proc. Soc. Exp. Biol. Med., 213,
193-195, (1996).
3. Runnegar, M.T. et al., Differential toxicity
of the protein phosphatase inhibitors
Product Information Sheet - C6762
reasonably stable in solution.
References
1. Carter, S.B., Nature, 213, 261 (1967).
2. Krishan, A. J., Cell Biol., 54, 657 (1972).
3. Prescott, D.M. et al., J. Exp. Cell Res., 71, 480
(1972).
4. Carter
Product Information Sheet - 30382
reasonably stable in solution.
References
1. Carter, S.B., Nature, 213, 261 (1967).
2. Krishan, A. J., Cell Biol., 54, 657 (1972).
3. Prescott, D.M. et al., J. Exp. Cell Res., 71, 480
(1972).
4. Carter
Product Information Sheet - D1641
reasonably stable in solution.
References
1. Carter, S.B., Nature, 213, 261 (1967).
2. Krishan, A. J., Cell Biol., 54, 657 (1972).
3. Prescott, D.M. et al., J. Exp. Cell Res., 71, 480
(1972).
4. Carter
Product Information Sheet - C6637
reasonably stable in solution.
References
1. Carter, S.B., Nature, 213, 261 (1967).
2. Krishan, A. J., Cell Biol., 54, 657 (1972).
3. Prescott, D.M. et al., J. Exp. Cell Res., 71, 480
(1972).
4. Carter
Product Information Sheet - C2149
reasonably stable in solution.
References
1. Carter, S.B., Nature, 213, 261 (1967).
2. Krishan, A. J., Cell Biol., 54, 657 (1972).
3. Prescott, D.M. et al., J. Exp. Cell Res., 71, 480
(1972).
4. Carter
Product Information Sheet - C0889
reasonably stable in solution.
References
1. Carter, S.B., Nature, 213, 261 (1967).
2. Krishan, A. J., Cell Biol., 54, 657 (1972).
3. Prescott, D.M. et al., J. Exp. Cell Res., 71, 480
(1972).
4. Carter
Product Information Sheet - C8273
reasonably stable in solution.
References
1. Carter, S.B., Nature, 213, 261 (1967).
2. Krishan, A. J., Cell Biol., 54, 657 (1972).
3. Prescott, D.M. et al., J. Exp. Cell Res., 71, 480
(1972).
4. Carter
Product Information - PPC2020
et al., Effect of
bromotetramisole on renal phosphate
excretion. Proc. Soc. Exp. Biol. Med.,
213, 193-195 (1996).
7. Runnegar, M.T. et al., Differential toxicity
of the protein phosphatase inhibitors
Quality Control Ranges: MILLIPLEX® MAP Human Cytokine/ Chemokine Magnetic Bead Panel
Control 2 498 – 1035 pg/mL
IFN α 2 Control 1 91 – 189 pg/mL IL-8 Control 1 102 – 213 pg/mL
DataSheet - P0044
References
1. Honkanen, R.E., FEBS Lett., 330(3), 283-286
(1993).
2. Onsgard-Meyer, M. et al., Proc. Soc. Exp. Biol.
Med., 213(2), 193-195 (1996).
3. Runnegar, M.T. et al., J. Pharmacol. Exp. Ther
XP725 Antibody Number-Lot Number 071M4826
254 255 256 277 278 279 280
3.5 209 210 211 212 233 234 235 236 257 258 259 260 281 282 283 284
3.6 213 214 215 216 237 238 239 240 261 262 263 264 285 286 287 288
4.1 289
Product Information Sheet - PR0100
E11 At5g10760 247
E12 At5g27600 171
F1 At1g02920 213
F2 At2g14560 151
F3 At4g04490 160
F4 At1g24140 193
Product Information - CSAA1
Clone:PK-G4 P8083 Signal Transduction M n/d n/d y
212 PKD P3987 Signal Transduction P y y n/d
213 Map Kinase Phosphatase-1 (MKP-1) M3787 Signal Transduction P y n/d n/d
214 Protein phosphatase 1α
Neurotoxicity and Neurite Outgrowth Assay
Content Screening Reagent Toolkits
HCS100 Hepatotoxicity Assay, Human HepG2 cells
HCS201–213, 216 HCS Kits for Cell Cycle and Proliferation
HCS223-225 DNA Damage HCS kits
An Update on Ligands for Prostanoid Receptors
FitzGerald, G.A., J. Clin. Invest., 108, 25-30 (2001).
12. Regan, J.W., et al., Mol. Pharmacol., 46, 213-220 (1994).
13. Toh, H., et al., FEBS Lett., 361, 17-21 (1995).
14. Hatae, N. et al., J. Biochem.
Protocol: Rat/Mouse Ghrelin (Active)
317 101%
1,000 1,156 109% 1,079 96%
Mouse
0 (Basal) 136 -- 213 --
50
Reprint: Industrial application of impurity flocculation to streamline antibody purification processes
inactivation step in the
manufacture of albumin. Parametric and validation studies.
Biologicals 31(3), 213–221 (2003).
28 Korneyeva M, Hotta J, Lebing W, Rosenthal R, Franks L,
Petteway S. Enveloped virus
Protocol- EZRGRA-90K
174 116%
200 296 115% 317 101%
1,000 1,156 109% 1,079 96%
Mouse
0 (Basal) 136 - 213 -
50 193 114% 259 92%
200 359 112% 396 92%
1,000 1,166 103%
User Guide Equinox SOP Software 2.1 for Windows XP
..
Contenido — i
193
193
193
194
194
195
198
199
199
199
200
202
202
202
203
203
203
204
204
205
205
206
206
207
207
208
208
209
209
210
210
210
211
211
213
213
213
214
214
215
215
216
216
Inhibitor Sourcebook 3rd Edition
for PKCßII, 213 nM for
PKCg, and 175 nM for PKC). Inhibits carbachol-evoked noradrenaline release (IC50 = 600 nM).
1 mg
Ro-31-8220 557520 {3-[1-[3-(Amidinothio)propyl-1h-indol-3-yl]-3-(1-methyl-1h-indol
Corticotropin-Releasing Factor Receptor Antagonists- Potential Novel Therapies for Human Disease
Endocrinology, 57, 599-607 (1955).
2. Saffran, M., et al., Endocrinology, 57, 439-444 (1955).
3. Vale, W., et al., Science, 213, 1394-1397 (1981).
4. Chen, R., et al., Proc. Natl. Acad. Sci. USA, 90, 8967-8971 (1993
XP725 Antibody List Lot 129K4831
Cathepsin D C0715 1509 CTSD M NP_001900.1 y n/d n/d
146 Cathepsin L C2970 1514 CTSL1 M NP_001903.1 y y y
213 DAPK D2178 1611 DAP M NP_004385.1 y n/d n/d
214
XP725 Antibody List Lot 129K4830
Cathepsin D C0715 1509 CTSD M NP_001900.1 y n/d n/d
146 Cathepsin L C2970 1514 CTSL1 M NP_001903.1 y y y
213 DAPK D2178 1611 DAP M NP_004385.1 y n/d n/d
214
1/3